BackgroundCheck.run
Search For

Shirley Zhu Chen, 5615 Zeek Rd, Morris Plains, NJ 07950

Shirley Chen Phones & Addresses

Morris Plains, NJ   

11 E Broadway #4A, New York, NY 10038   

249 E Broadway #2 2, New York, NY 10002   

311 W Broadway APT 2E, New York, NY 10013   

Flushing, NY   

1373 Dahill Rd #1, Brooklyn, NY 11204   

Fremont, CA   

Sayreville, NJ   

Palm Coast, FL   

Work

Company: Infohome realty Address: 20045 Stevens Creek Blvd Ste 1, Cupertino, CA 95014 Industries: Real Estate Agents and Managers

Mentions for Shirley Zhu Chen

Career records & work history

Lawyers & Attorneys

Shirley Chen Photo 1

Shirley Chen

Medicine Doctors

Shirley Chen

Specialties:
Family Medicine
Work:
Pacific Medical CentersPacific Medical Center
12910 Totem Lk Blvd NE STE 101, Kirkland, WA 98034
425-8145080 (phone) 425-8145009 (fax)
Site
Education:
Medical School
Univ of Toronto, Fac of Med, Toronto, Ont, Canada
Graduated: 1995
Conditions:
Abnormal Vaginal Bleeding, Acute Sinusitis, Allergic Rhinitis, Anxiety Phobic Disorders, Bronchial Asthma, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Female Infertility, Gastroesophageal Reflux Disease (GERD), Hypertension (HTN), Hypothyroidism, Menopausal and Postmenopausal Disorders, Migraine Headache, Polycystic Ovarian Syndrome (PCOS), Vitamin D Deficiency
Languages:
English, Spanish
Description:
Dr. Chen graduated from the Univ of Toronto, Fac of Med, Toronto, Ont, Canada in 1995. She works in Kirkland, WA and specializes in Family Medicine. Dr. Chen is affiliated with Swedish Edmonds Hospital and Swedish Medical Center - First Hill.

License Records

Shirley Chen

Licenses:
License #: 55111 - Expired
Category: Nursing Support
Issued Date: May 30, 2002
Effective Date: May 30, 2004
Type: Nurse Aide

Shirley Chen resumes & CV records

Resumes

Shirley Chen Photo 46

Shirley Chen - New York, NY

Work:
SIMON-KUCHER & PARTNERS - Boston, MA 2011 to 2013
Marketing Strategy Consultant
COVIDIEN - Norwalk, CT 2010 to 2010
Associate Brand Manager Intern
L'OREAL USA - Clark, NJ 2006 to 2008
Business Analyst
PROCTER & GAMBLE - Cincinnati, OH 2005 to 2005
Global Analytics Intern
INTEL CORPORATION - Chandler, AZ 2004 to 2004
Supply Chain Analytics Intern
Education:
CORNELL UNIVERSITY, Johnson Graduate School of Management - Ithaca, NY May 2011
Master of Business Administration
CORNELL UNIVERSITY - Ithaca, NY Aug 2006
Bachelor of Science in Operations Research & Industrial Engineering
Skills:
SPSS, Palisade Risk, Sawtooth Software, Conjoint Analysis
Shirley Chen Photo 47

Shirley Chen - Long Beach, CA

Work:
Providence Health and Services Mar 2014 to 2000
Epic Implementation Technician
Red Cross Disaster Services Dec 2013 to 2000
FAST (First Aid Services Team), Client Casework, and Disaster Health Volunteer
Vitas Hospice Dec 2013 to 2000
Friendly Visitor Volunteer
Foothill Community Health Center - San Jose, CA Dec 2013 to Mar 2014
Nursing Volunteer
University of California Irvine Outreach Clinic Oct 2010 to Aug 2013
Nursing Volunteer
Illumination Foundation Recuperative Care Program Oct 2010 to Aug 2013
Medical Specialist
Nursing Science Student Association Sep 2012 to Jun 2013
Breakthrough to Nursing Representative and Secretary
Language Exchange Program Sep 2011 to Jun 2013
Vice President & Secretary
Center for Future Health Professionals - Irvine, CA Nov 2012 to May 2013
Nursing Mentor/Coordinator
Nursing Science Student Association (NSSA) Sep 2011 to Jun 2012
Project's Coordinator
Campus Village Housing - Irvine, CA Jun 2010 to Jun 2011
Community Assistant
Education:
University of California - Irvine, CA 2009 to 2013
Bachelor of Science in Nursing Science
International Christian University - Tokyo, JP 2012
Summer Courses in Intensive Japanese

Publications & IP owners

Us Patents

Therapeutic Use Of Tumor Necrosis Factor-Alpha Mutein

US Patent:
2006026, Nov 23, 2006
Filed:
Dec 19, 2003
Appl. No.:
10/741161
Inventors:
Gang Chen - Shanghai, CN
Xinjiang Du - Shanghai, CN
Dezheng Wu - Beijing, CN
Weijing Zhang - Beijing, CN
Shirley Chen - Sunnyvale CA, US
International Classification:
A61K 38/19
A61K 38/17
A61K 31/704
A61K 31/522
A61K 33/24
US Classification:
424085100, 424649000, 514008000, 514183000, 514034000, 514251000, 514263310
Abstract:
Improved methods for treating neoplastic diseases such as cancer are provided by using muteins of human tumor necrosis factor-alpha (TNF-α). Compared to wild-type human TNF-α these therapeutic TNF muteins have higher specific anti-tumor activity, but with much reduced systemic toxicity and milder side effects such chills and fever. In addition, potentially synergistic, novel combinations of the inventive TNF-α muteins with other anti-neoplastic agents are provided for effectively treating patients having particular types of cancer or malignancy or at particular stages of cancer development, and for mitigating resistance of the patients to treatment of non-TNF antineoplastic agents.

Complex Of Anti-Fungal Agent And Cyclodextrin And Method

US Patent:
4883785, Nov 28, 1989
Filed:
Jul 27, 1984
Appl. No.:
6/635030
Inventors:
Wing-Sun Chow - Upper Montclair NJ
Shirley C. Chen - Edison NJ
Peter Timmins - Morton, Wirral, Merseyside, GB
International Classification:
A61K 3170
C07H 1708
US Classification:
514 31
Abstract:
An anti-fungal complex formed of a polyene anti-fungal agent, such as amphotericin B, and cyclodextrin, preferably. gamma. -cyclodextrin, is provided. The complex which includes amphoterin B has improved water solutility and stability over prior art amphotericin B anti-fungal agents. A method for forming the complex is also provided wherein anti-fungal agent, such as amphoterin B, is dissolved in an aqueous solution of cyclodextrin of pH ranging from about 9 to about 12 and the resulting solution is maintained at a pH ranging from about 6 to about 8 to form the subject complex. The solution can be lyophilized as desired to achieve higher solubility.

Systems And Methods For Determining Consensus Base Calls In Nucleic Acid Sequencing

US Patent:
2021006, Mar 4, 2021
Filed:
Aug 28, 2020
Appl. No.:
17/006124
Inventors:
- Menlo Park CA, US
Shirley Chen - San Jose CA, US
David Burkhardt - San Francisco CA, US
Christopher Chang - Mountain View CA, US
International Classification:
G16B 30/10
G16B 40/00
Abstract:
Systems and methods for determining consensus base calls in nucleic acid sequencing are provided. A sequencing dataset is obtained corresponding to a plurality of base reads for a first base position within a plurality of base positions of a target nucleic acid molecule. The sequencing dataset includes at least two features, for each base read of the plurality of base reads. The at least two features are selected from among the features: a nucleotide base, a read quality score, a strand identifier, a trinucleotide context of the base read, and a confidence score associated with the trinucleotide context. The sequencing dataset is transformed into a feature tensor representing a distribution of the plurality of features in the sequencing dataset. The feature tensor is assessed with a classifier to determine a consensus base call for the first base position. The consensus base call comprises a predicted nucleotide base.

Generating Dynamic Links For Network-Accessible Content

US Patent:
2020033, Oct 22, 2020
Filed:
Jun 30, 2020
Appl. No.:
16/917265
Inventors:
- New York NY, US
Christopher Ho Sang - Forest Hills NY, US
Shirley Chen - New York NY, US
International Classification:
G06F 9/445
G06F 16/958
Abstract:
In an example method, a request for a dynamic access link is received from a first device. The request includes data identifying a first network resource. A subject associated with the first network resource is identified, and one or more additional network resources pertaining to the subject are determined. The dynamic access link is determined, and the dynamic access link is provided to the first device. A network resource access request is received from a second device. The network resource access request is generated responsive to the dynamic access link being selected. Responsive to receiving the network resource access request, at least one of the first resource or the one or more additional network resources is chosen, and a network address of the chosen resource is provided to the second device.

Generating Dynamic Links For Network-Accessible Content

US Patent:
2018036, Dec 20, 2018
Filed:
Jan 25, 2018
Appl. No.:
15/880411
Inventors:
- New York NY, US
Christopher Ho Sang - Forest Hills NY, US
Shirley Chen - New York NY, US
International Classification:
G06F 9/445
G06F 17/30
Abstract:
In an example method, a request for a dynamic access link is received from a first device. The request includes data identifying a first network resource. A subject associated with the first network resource is identified, and one or more additional network resources pertaining to the subject are determined. The dynamic access link is determined, and the dynamic access link is provided to the first device. A network resource access request is received from a second device. The network resource access request is generated responsive to the dynamic access link being selected. Responsive to receiving the network resource access request, at least one of the first resource or the one or more additional network resources is chosen, and a network address of the chosen resource is provided to the second device.

Multifunctional Composite Skin Or Wound Dressing As Regenerative Skin Substitute

US Patent:
2018008, Mar 29, 2018
Filed:
Nov 24, 2017
Appl. No.:
15/822020
Inventors:
Shirley X. CHEN - Sunnyvale CA, US
Guangming XIONG - Hangzhou, CN
International Classification:
A61L 15/22
A61L 15/52
A61L 15/42
A61L 15/18
Abstract:
With its unique composite network structure of micro-cavities and microfilaments, a material can mimic the skin barrier function: capable of shielding contamination, moisture absorption, moisture retention, breathability, pliability and adhesion. It is capable of absorbing wound exudates to facilitate rapid, non-invasive autolytic debridement and bi-directional regulation to ensure sufficient drainage, but also targetedly and compartmentally retaining exudates in the dressing to maintain a semi-occlusive local environment with a physiological moisture balance, which is conducive to intercellular and intracellular signal transduction, promoting migration of autologous fibroblasts and epithelial cells, regeneration of granulation tissue and epithelium, accelerating physiological healing and restoration, and reducing recurrence. It has been clinically proven to accelerate the healing of acute skin injuries and chronic ulcer wounds, achieve an excellent healing quality, and avoid/minimize traumatic skin grafting so as to reduce the pain and scarring of patients, and restore the physiological function and appearance of the body.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.